Targeting the effects of omega-3 and omega-6 fatty acid supplementation on schizophrenic spectrum disorders: role of neuroimaging.
Sota
M
M
Allegri
C
C
Cortesi
M
M
Barale
F
F
Politi
P
P
Fusar-Poli
P
P
D001921:Brain / Q000378:metabolism* / Q000503:physiopathology; D019587:Dietary Supplements; D016503:Drug Delivery Systems; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage* / Q000502:physiology; D043371:Fatty Acids, Omega-6 / Q000008:administration & dosage* / Q000502:physiology; D006801:Humans; D008279:Magnetic Resonance Imaging; D012559:Schizophrenia / Q000175:diagnosis / Q000178:diet therapy* / Q000378:metabolism*
D015525:Fatty Acids, Omega-3; D043371:Fatty Acids, Omega-6